Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$932K Buy
4,133
+45
+1% +$10.9K 0.1% 71
2022
Q2
$995K Sell
4,088
-33
-0.8% -$8.09K 0.11% 68
2022
Q1
$996K Sell
4,121
-20,586
-83% -$4.73M 0.1% 67
2021
Q4
$5.56M Buy
24,707
+2,829
+13% +$597K 0.51% 37
2021
Q3
$4.65M Buy
21,878
+1,932
+10% +$445K 0.42% 38
2021
Q2
$4.86M Buy
19,946
+3,035
+18% +$747K 0.42% 36
2021
Q1
$4.21M Buy
16,911
+2,007
+13% +$479K 0.39% 38
2020
Q4
$3.43M Buy
14,904
+1,130
+8% +$261K 0.34% 40
2020
Q3
$3.5M Buy
13,774
+2,048
+17% +$507K 0.39% 35
2020
Q2
$2.77M Buy
11,726
+2,299
+24% +$525K 0.38% 38
2020
Q1
$1.91M Buy
9,427
+6,616
+235% +$1.45M 0.33% 37
2019
Q4
$678K Buy
2,811
+910
+48% +$201K 0.13% 57
2019
Q3
$368K Buy
1,901
+185
+11% +$35.5K 0.08% 65
2019
Q2
$316K Buy
1,716
+267
+18% +$47.8K 0.07% 72
2019
Q1
$275K Buy
+1,449
New +$277K 0.06% 78
2018
Q2
Sell
-2,036
Closed -$347K 94
2018
Q1
$347K Hold
2,036
0.08% 88
2017
Q4
$354K Hold
2,036
0.08% 84
2017
Q3
$380K Buy
+2,036
New +$361K 0.09% 81

Other funds holding AMGN

Brightworth's AMGN Position: Q3 2022 in Review

Brightworth increased its Amgen (AMGN) stake by 1.1% in Q3 2022, buying an estimated $10.9K and bringing the position to 4,133 shares worth $932K. The position accounts for 0.1% of the portfolio, ranked #71.

Brightworth first reported a position in AMGN in Q3 2017 and has held it in 18 quarters since. The position peaked at $5.56M in Q4 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Brightworth held 4,133 shares of Amgen worth $932K as of Q3 2022.
  • Brightworth bought 45 Amgen shares in Q3 2022, an estimated $10.9K.
  • Amgen made up 0.1% of Brightworth's portfolio in Q3 2022, its #71 holding.
  • Brightworth first reported a position in Amgen in Q3 2017 and has held it in 18 quarters since.
  • Brightworth's Amgen position peaked at $5.56M in Q4 2021.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Brightworth's 13F filing for Q3 2022, filed 28 Oct 2022.